Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity.

[1]  L. Bolondi,et al.  Long term effects of gluten-free diet in non-celiac wheat sensitivity. , 2017, Clinical nutrition.

[2]  K. Lundin,et al.  Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. , 2017, Gastroenterology.

[3]  K. Whelan,et al.  A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial. , 2017, Gastroenterology.

[4]  D. Schuppan,et al.  Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells. , 2017, Gastroenterology.

[5]  A. Carroccio,et al.  Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients After Gluten Challenge in Double‐Blind, Placebo‐Controlled Trials , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  Lisa M Bramer,et al.  Dynamics of the human gut microbiome in Inflammatory Bowel Disease , 2017, Nature Microbiology.

[7]  D. Sanders,et al.  Prevalence and Characterization of Self-Reported Gluten Sensitivity in The Netherlands , 2016, Nutrients.

[8]  A. Berstad,et al.  Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols , 2016, Digestion.

[9]  G. Van Domselaar,et al.  The Gut Microbiota in Immune-Mediated Inflammatory Diseases , 2016, Front. Microbiol..

[10]  R. Gearry,et al.  Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date , 2016, Clinical and experimental gastroenterology.

[11]  A. Keshteli,et al.  FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial , 2016, Gut.

[12]  F. Meacci,et al.  Diagnostic accuracy of anti-gliadin antibodies in Non Celiac Gluten Sensitivity (NCGS) patients: A dual statistical approach. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[13]  L. Böhn,et al.  Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. , 2015, Gastroenterology.

[14]  V. Villanacci,et al.  Randomised clinical study: gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non‐coeliac gluten sensitivity , 2015, Alimentary pharmacology & therapeutics.

[15]  D. Schuppan,et al.  Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts’ Criteria , 2015, Nutrients.

[16]  C. Fraser,et al.  Functional Dynamics of the Gut Microbiome in Elderly People during Probiotic Consumption , 2015, mBio.

[17]  C. Manichanh,et al.  Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena? , 2015, The American Journal of Gastroenterology.

[18]  V. Young,et al.  The gut microbiome in health and in disease , 2015, Current opinion in gastroenterology.

[19]  H. Galipeau,et al.  Gut microbes and adverse food reactions: Focus on gluten related disorders , 2014, Gut microbes.

[20]  P. Gibson,et al.  Diets that differ in their FODMAP content alter the colonic luminal microenvironment , 2014, Gut.

[21]  A. Stallmach,et al.  Ergebnisse einer S2k-Konsensuskonferenz der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen (DGVS) gemeinsam mit der Deutschen Zöliakie-Gesellschaft (DZG) zur Zöliakie, Weizenallergie und Weizensensitivität , 2014, Zeitschrift für Gastroenterologie.

[22]  Sjoerd Post,et al.  The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system , 2014, Immunological reviews.

[23]  M. C. G. Gouveia Pelúzio,et al.  Intestinal Microbiota and Probiotics in Celiac Disease , 2014, Clinical Microbiology Reviews.

[24]  Jacques Ravel,et al.  An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform , 2014, Microbiome.

[25]  D. Aust,et al.  [Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in conjunction with the German Coeliac Society (DZG) regarding coeliac disease, wheat allergy and wheat sensitivity]. , 2014, Zeitschrift fur Gastroenterologie.

[26]  P. Gibson,et al.  A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. , 2014, Gastroenterology.

[27]  Robert C. Edgar,et al.  UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.

[28]  Jane G Muir,et al.  No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. , 2013, Gastroenterology.

[29]  K. Lundin,et al.  Mucosal Cytokine Response After Short-Term Gluten Challenge in Celiac Disease and Non-Celiac Gluten Sensitivity , 2013, The American Journal of Gastroenterology.

[30]  W. Khan,et al.  Goblet Cells and Mucins: Role in Innate Defense in Enteric Infections , 2013, Pathogens.

[31]  T. Libermann,et al.  Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4 , 2012, The Journal of experimental medicine.

[32]  M. Soresi,et al.  Non-Celiac Wheat Sensitivity Diagnosed by Double-Blind Placebo-Controlled Challenge: Exploring a New Clinical Entity , 2012, The American Journal of Gastroenterology.

[33]  F. Tovoli,et al.  Serological Tests in Gluten Sensitivity (Nonceliac Gluten Intolerance) , 2012, Journal of clinical gastroenterology.

[34]  K. Whelan,et al.  Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. , 2012, The Journal of nutrition.

[35]  David S. Wishart,et al.  METAGENassist: a comprehensive web server for comparative metagenomics , 2012, Nucleic Acids Res..

[36]  Marcus J Claesson,et al.  An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota , 2011, Gut.

[37]  Sebastian Tims,et al.  Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. , 2011, Gastroenterology.

[38]  Jane G Muir,et al.  Gluten Causes Gastrointestinal Symptoms in Subjects Without Celiac Disease: A Double-Blind Randomized Placebo-Controlled Trial , 2011, The American Journal of Gastroenterology.

[39]  G. Tack,et al.  The spectrum of celiac disease: epidemiology, clinical aspects and treatment , 2010, Nature Reviews Gastroenterology &Hepatology.

[40]  M. Blaut,et al.  Metabolic diversity of the intestinal microbiota: implications for health and disease. , 2007, The Journal of nutrition.

[41]  Enzo Grossi,et al.  Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S) , 2006, Health and quality of life outcomes.

[42]  J. Svedlund,et al.  GSRS—A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease , 1988, Digestive Diseases and Sciences.

[43]  S. Lewis,et al.  Stool form scale as a useful guide to intestinal transit time. , 1997, Scandinavian journal of gastroenterology.